Neuroscientist
Claire is currently completing her MBA at the University of Warwick.
Claire works with expert researchers to develop scientific programming for the Alzheimer’s Association International Conference (AAIC), the largest international meeting dedicated to dementia science. She also presents on the Association’s role in scientific advancements and the state of Alzheimer’s and dementia research.
As an Atlantic Fellow for Equity in Brain Health, Claire's research focused on modifiable factors associated with risk for Alzheimer’s and other dementias.
Throughout her career, Claire has combined her research with voluntary work in community-based initiatives aimed at promoting healthy aging and supporting people living with dementia.
Claire completed her doctoral and postdoctoral studies at the University of Oxford (2007-2019), before moving to the University of California San Francisco as an Atlantic Fellow for Equity in Brain Health (2017-2019). As a researcher, she has published over eighty journal articles that investigate the aging process, age-related diseases, and modifiable factors that promote brain health, including in Alzheimer’s and Dementia, Biological Psychiatry, JAMA Psychiatry, the Journal of Neuroscience, Lancet Public Health, Nature Human Behaviour, Nature Neuroscience, Neurology, and Sleep. As Senior Director, Scientific Programs and Outreach, at the Alzheimer’s Association (2020-2024) Claire led the strategy, development, management and evaluation of scientific programming across the International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and the Alzheimer’s Association International Conference (AAIC) suite of events. In this role she also served as a spokesperson for the Association, communicating research advancements in Alzheimer’s at conferences, events, and in major media outlets, including The Washington Post, USA Today, The Daily Mail, New York Post and CNN. Claire is currently completing her MBA at the University of Warwick.
Claire
a NoteHave ideas for global brain health or a collaboration? I would love to hear from you. Feel free to send an introductory note.